MedTrace Logo

ACP for Local Application in Ankle Arthrodesis

NCT01131455 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2014-11-13

Study results available
· View outcomes & findings →

Summary

To compare the outcomes of patients who undergo three different types of surgeries for ankle fusion and reconstruction.

Conditions

  • Ankle Arthritis

Interventions

BIOLOGICAL

Autologous Concentrated Plasma

Autologous blood products have created a growing interest for use in a number of orthopedic therapies. The healing effects of plasma are supported by growth factors released by platelets. These growth factors induce a healing process wherever they are applied. The Arthrex ACP System is a cost-effective method of concentrating growth factors for therapeutic use.

Sponsors & Collaborators

  • Columbia Orthopaedic Group, LLP

    lead OTHER

Principal Investigators

  • Paul Shurnas · Columbia Orthopaedic Group

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01131455 on ClinicalTrials.gov